Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2a Study of Boceprevir for the Treatment of Genotype 6 Hepatitis C

NCT01949168 is registered in ClinicalTrials.gov with St Vincent's Hospital Melbourne as lead sponsor.

NCT NCT01949168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01949168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2a Study of Boceprevir for the Treatment of Genotype 6 Hepatitis C
Lead sponsor
St Vincent's Hospital Melbourne
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2013
Completion date
Not reported
Enrollment
30 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c